These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10599051)

  • 1. Cardioprotective effects of abciximab (ReoPro) in an isolated perfused rat heart model of ischemia and reperfusion.
    Campbell B; Chuhran CM; Lefer DJ; Lefer AM
    Methods Find Exp Clin Pharmacol; 1999 Oct; 21(8):529-34. PubMed ID: 10599051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts.
    Lefer AM; Campbell B; Shin YK; Scalia R; Hayward R; Lefer DJ
    Circulation; 1999 Jul; 100(2):178-84. PubMed ID: 10402448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart.
    Campbell B; Adams J; Shin YK; Lefer AM
    J Mol Cell Cardiol; 1999 Feb; 31(2):467-76. PubMed ID: 10093058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of N,N,N-trimethylsphingosine following ischemia and reperfusion in the isolated perfused rat heart.
    Campbell B; Shin YK; Scalia R; Lefer AM
    Cardiovasc Res; 1998 Aug; 39(2):393-400. PubMed ID: 9798524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of endothelium/leukocytes/platelet interaction on myocardial ischemia--reperfusion injury.
    Habazettl H; Hanusch P; Kupatt C
    Z Kardiol; 2000; 89 Suppl 9():IX/92-5. PubMed ID: 11151804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
    Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
    Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c7E3Fab reduces postischemic leukocyte-thrombocyte interaction mediated by fibrinogen. Implications for myocardial reperfusion injury.
    Kupatt C; Habazettl H; Hanusch P; Wichels R; Hahnel D; Becker BF; Boekstegers P
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2226-32. PubMed ID: 11031208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolin-1 peptide exerts cardioprotective effects in myocardial ischemia-reperfusion via nitric oxide mechanism.
    Young LH; Ikeda Y; Lefer AM
    Am J Physiol Heart Circ Physiol; 2001 Jun; 280(6):H2489-95. PubMed ID: 11356603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective actions of a monoclonal antibody against CD-18 in myocardial ischemia-reperfusion injury.
    Lefer DJ; Shandelya SM; Serrano CV; Becker LC; Kuppusamy P; Zweier JL
    Circulation; 1993 Oct; 88(4 Pt 1):1779-87. PubMed ID: 8104739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion.
    Young LH; Ikeda Y; Scalia R; Lefer AM
    Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1453-9. PubMed ID: 11009429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins.
    Lefer AM; Campbell B; Scalia R; Lefer DJ
    Circulation; 1998 Sep; 98(13):1322-8. PubMed ID: 9751682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a metalloproteinase that truncates P-selectin glycoprotein ligand on neutrophil-induced cardiac dysfunction in ischemia/reperfusion.
    Lefer AM; Campbell B; Shin YK
    J Mol Cell Cardiol; 1998 Dec; 30(12):2561-6. PubMed ID: 9990528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of P2Y12 or GPIIb/IIIa receptors reduces platelet-mediated myocardial injury after ischaemia and reperfusion in isolated rat hearts.
    Barrabés JA; Inserte J; Mirabet M; Quiroga A; Hernando V; Figueras J; Garcia-Dorado D
    Thromb Haemost; 2010 Jul; 104(1):128-35. PubMed ID: 20431845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endothelin A receptor antagonist LU 135252 protects the myocardium from neutrophil injury during ischaemia/reperfusion.
    Gonon AT; Wang QD; Pernow J
    Cardiovasc Res; 1998 Sep; 39(3):674-82. PubMed ID: 9861311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
    Straub A; Wendel HP; Azevedo R; Ziemer G
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):617-21. PubMed ID: 15784360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C betaII peptide inhibitor exerts cardioprotective effects in rat cardiac ischemia/reperfusion injury.
    Omiyi D; Brue RJ; Taormina P; Harvey M; Atkinson N; Young LH
    J Pharmacol Exp Ther; 2005 Aug; 314(2):542-51. PubMed ID: 15878997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel beneficial effects of defibrotide, an endothelium protecting agent, following ischemia and reperfusion in the isolated perfused rat heart.
    Shin YK; Campbell B; Lefer AM
    Methods Find Exp Clin Pharmacol; 1998; 20(6):463-71. PubMed ID: 9789870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase inhibition exerts cardioprotective effects in myocardial ischemia/reperfusion via inhibition of superoxide release.
    Young LH; Ikeda Y; Lefer AM
    Methods Find Exp Clin Pharmacol; 2001 Apr; 23(3):107-14. PubMed ID: 11523308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PR-39, a proline/arginine-rich antimicrobial peptide, exerts cardioprotective effects in myocardial ischemia-reperfusion.
    Ikeda Y; Young LH; Scalia R; Ross CR; Lefer AM
    Cardiovasc Res; 2001 Jan; 49(1):69-77. PubMed ID: 11121797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early recovery of microvascular perfusion induced by t-PA in combination with abciximab or eptifibatide during postischemic reperfusion.
    Bertuglia S; Giusti A
    BMC Cardiovasc Disord; 2002 Jun; 2():10. PubMed ID: 12086588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.